80 FR 28 pgs. 7615-7616 - Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications
Type: NOTICEVolume: 80Number: 28Pages: 7615 - 7616
Pages: 7615, 7616Docket number: [Docket Nos. FDA-2014-M-0867, FDA-2014-M-0874, FDA-2014-M-0875, FDA-2014-M-1060, FDA-2014-M-1064, FDA-2014-M-1113, FDA-2014-M-1114, FDA-2014-M-1193, FDA-2014-M-1265, FDA-2014-M-1279, and FDA-2014-M-1280]
FR document: [FR Doc. 2015-02783 Filed 2-10-15; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA-2014-M-0867, FDA-2014-M-0874, FDA-2014-M-0875, FDA-2014-M-1060, FDA-2014-M-1064, FDA-2014-M-1113, FDA-2014-M-1114, FDA-2014-M-1193, FDA-2014-M-1265, FDA-2014-M-1279, and FDA-2014-M-1280]
Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is publishing a list of premarket approval applications (PMAs) that have been approved. This list is intended to inform the public of the availability of safety and effectiveness summaries of approved PMAs through the Internet and the Agency's Division of Dockets Management.
ADDRESSES:
Submit written requests for copies of summaries of safety and effectiveness data to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. Please cite the appropriate docket number as listed in table 1 when submitting a written request. See the SUPPLEMENTARY INFORMATION section for electronic access to the summaries of safety and effectiveness.
FOR FURTHER INFORMATION CONTACT:
Nicole Wolanski, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 1650, Silver Spring, MD 20993-0002, 301-796-6570.
SUPPLEMENTARY INFORMATION:
I. Background
In accordance with sections 515(d)(4) and (e)(2) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 360e(d)(4) and (e)(2)), notification of an order approving, denying, or withdrawing approval of a PMA will continue to include a notice of opportunity to request review of the order under section 515(g) of the FD&C Act. The 30-day period for requesting reconsideration of an FDA action under § 10.33(b) (21 CFR 10.33(b)) for notices announcing approval of a PMA begins on the day the notice is placed on the Internet. Section 10.33(b) provides that FDA may, for good cause, extend this 30-day period. Reconsideration of a denial or withdrawal of approval of a PMA may be sought only by the applicant; in these cases, the 30-day period will begin when the applicant is notified by FDA in writing of its decision.
The regulations provide that FDA publish a quarterly list of available safety and effectiveness summaries of PMA approvals and denials that were announced during that quarter. The following is a list of approved PMAs for which summaries of safety and effectiveness were placed on the Internet from July 1, 2014, through September 30, 2014. There were no denial actions during this period. The list provides the manufacturer's name, the product's generic name or the trade name, and the approval date.
| PMA No., Docket No. | Applicant | Trade name | Approval date |
|---|---|---|---|
| P130021/S002, FDA-2014-M-0867 | Medtronic CoreValve LLC | Medtronic CoreValve TM System (MCS) | June 12, 2014. |
| P130009, FDA-2014-M-0874 | Edwards Lifesciences, LLC | Edwards SAPIEN XT TM Transcatheter Heart Valve and Accessories | June 16, 2014. |
| P130029, FDA-2014-M-0875 | Bard Peripheral Vascular, Inc | Fluency® Plus Endovascular Stent Graft | June 17, 2014. |
| P130011, FDA-2014-M-1064 | Sorin Group Canada, Inc | Freedom SOLO Stentless Heart Valve and SOLO Smart Heart Valve | June 24, 2014. |
| P130030, FDA-2014-M-1060 | Boston Scientific Corp | REBEL TM Platinum Chromium Coronary Stent System (Monorail TM and Over-The-Wire) | June 27, 2014. |
| P090029, FDA-2014-M-1113 | Medtronic Sofamor Danek USA, Inc | Prestige® LP Cervical Disc | July 24, 2014. |
| H130005, FDA-2014-M-1114 | MicroVention, Inc | Low-Profile Visualized Intraluminal Support Device (LVIS and LVIS Jr.) | July 25, 2014. |
| P130017, FDA-2014-M-1193 | Exact Sciences, Inc | COLOGUARD TM | August 11, 2014. |
| H120003, FDA-2014-M-1265 | XVIVO Perfusion, Inc | XVIVO Perfusion System (XPS TM ) with STEEN Solution TM Perfusate | August 12, 2014. |
| H130004, FDA-2014-M-1280 | Plexision, Inc | Pleximmune TM | August 26, 2014. |
| P130020, FDA-2014-M-1279 | GE Healthcare | SenoClaire | August 26, 2014. |
[top]
II. Electronic Access
Persons with access to the Internet may obtain the documents at http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/PMAApprovals/default.htm.
Dated: February 5, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-02783 Filed 2-10-15; 8:45 am]
BILLING CODE 4164-01-P